13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 90 holding rows worth $3,101,466,678.
- Accession
- 0001791827-24-000004
- Filer
- CIK 1791827
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 90 entries on the cover page, a total value of $3,101,466,678 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,101,466,678 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 600,000 | $239,454,000 | dollars as filed | call |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 6,500,328 | $138,586,993 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 1,956,000 | $133,966,440 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 2,985,190 | $123,228,643 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 226,000 | $90,194,340 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,717,554 | $81,526,620 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,005,000 | $79,616,100 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 536,500 | $73,994,080 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 803,300 | $73,469,818 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 584,000 | $70,325,280 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 2,695,000 | $68,911,150 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 184,500 | $67,008,555 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 502,000 | $66,238,900 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 68,000 | $65,449,320 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,454,765 | $63,864,184 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 464,100 | $63,730,212 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 601,000 | $63,171,110 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 189,000 | $61,976,880 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,412,500 | $57,417,500 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 70,000 | $54,457,200 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 217,000 | $49,849,240 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,174,700 | $46,565,108 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 933,500 | $43,585,115 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 545,000 | $43,469,200 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 1,445,000 | $43,104,350 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 600,000 | $42,066,000 | dollars as filed | call |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 600,000 | $41,520,000 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 227,000 | $41,336,700 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 426,000 | $40,410,360 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 668,300 | $37,484,947 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 864,000 | $37,031,040 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 243,000 | $36,316,350 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 143,800 | $35,909,736 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 799,700 | $35,090,836 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 431,000 | $34,393,800 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 710,000 | $30,565,500 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 480,000 | $29,875,200 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 5,785,352 | $29,736,709 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,142,850 | $28,708,392 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,025,000 | $27,613,500 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 1,300,064 | $27,392,348 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 384,893 | $25,576,140 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,800,000 | $24,750,000 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 176,900 | $24,536,030 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 465,237 | $23,680,563 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 760,000 | $22,313,600 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 873,891 | $21,567,630 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 36,600 | $21,272,286 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 224,000 | $21,120,960 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 635,000 | $20,466,050 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 284,000 | $19,400,040 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 286,400 | $18,616,000 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,735,000 | $18,425,700 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 33,300 | $17,877,105 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 383,500 | $16,536,520 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 505,000 | $16,316,550 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 764,200 | $14,970,678 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 384,245 | $14,466,824 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 34,884,000 | $14,424,534 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 361,400 | $14,029,548 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,990,000 | $13,930,000 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 209,700 | $13,882,140 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 982,000 | $13,821,650 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 4,470,000 | $13,231,200 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 8,298,570 | $12,530,841 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 8,902,972 | $11,751,923 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 166,000 | $11,638,260 | dollars as filed | |
| RADNET INC | 750491102 | COM | 238,000 | $11,581,080 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 225,000 | $11,452,500 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 475,000 | $11,233,750 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 588,500 | $10,881,365 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 160,000 | $10,840,000 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,673,538 | $8,953,428 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 150,000 | $6,429,000 | dollars as filed | call |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 130,000 | $5,635,500 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,221,555 | $5,106,100 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 202,333 | $5,025,952 | dollars as filed | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 1,908,000 | $4,827,240 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 5,026,000 | $4,531,442 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 75,000 | $4,101,750 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 1,150,000 | $3,737,500 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X100 | CL A SHS | 3,000,000 | $3,480,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 2,413,000 | $3,354,070 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 445,706 | $2,995,144 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 675,000 | $2,531,250 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,448,728 | $2,129,630 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 300,000 | $1,578,000 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,188,178 | $1,188,178 | dollars as filed | |
| CAREMAX INC | 14171W202 | COM | 21,200 | $102,184 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 89,543 | $27,087 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-24-000004 | this filing | 2024-05-15 | acceptance time not in the bulk data set |